To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Appili Therapeutics strikes funding deal with The Lind Partners
Halifax, Nova Scotia-based Appili Therapeutics, an infectious disease biopharmaceutical company, has collected C$3.5 million in a convertible security financing agreement.
